Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
McKesson
UBS
US Army
Express Scripts
Mallinckrodt
Merck
Dow
Colorcon
QuintilesIMS

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,248,726

« Back to Dashboard

Which drugs does patent 6,248,726 protect, and when does it expire?

Patent 6,248,726 protects EXTRANEAL and is included in one NDA.

This patent has fourteen patent family members in nine countries.
Summary for Patent: 6,248,726
Title: Method of peritoneal dialysis using glucose polymer solutions
Abstract:There is described polysaccharides of high molecular weight for use in peritoneal dialysis. The polysaccharides are capable of dialysing human serum for long periods of time without causing damage to the peritoneum and are also capable of preventing loss of polymer from the peritoneum to the serum. There is also described a method of making the polysaccharides and pharmaceutical formulations containing them.
Inventor(s): Alsop; Ranulph Michael (Alderley Edge, GB), Forrester; Raymond Brian (Sandbach, GB), Manning; David John (Congleton, GB)
Assignee: M L Laboratories plc (London, GB)
Application Number:07/954,686
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 6,248,726

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Baxter Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 RX Yes Yes ➤ Subscribe ➤ Subscribe PERITONEAL DIALYSIS SOLUTION ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,248,726

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United KingdomBA85/15842Jun 22, 1985

International Patents Family Members for US Patent 6,248,726

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0207676 ➤ Subscribe
Australia 5881186 ➤ Subscribe
Germany 3689863 ➤ Subscribe
Denmark 288586 ➤ Subscribe
Finland 862563 ➤ Subscribe
Austria 106410 ➤ Subscribe
Australia 594060 ➤ Subscribe
Finland 86141 ➤ Subscribe
United Kingdom 8515842 ➤ Subscribe
United Kingdom 8610841 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Citi
Chinese Patent Office
Medtronic
Healthtrust
Moodys
Covington
Chubb
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot